Dietary soy isoflavones increase metastasis to lungs in an experimental model of breast cancer with bone micro-tumors

Clinical and Experimental Metastasis

Volumn 32, Issue 4, 2015, Pages 323-333

  Yang, Xujuan ^a   Belosay, Aashvini ^a   Hartman, James A ^a   Song, Huaxin ^b   Zhang, Yukun ^a   Wang, Wendan ^a   Doerge, Daniel R ^c   Helferich, William G ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Bone micro metastasis; Breast cancer; Dietary soy isoflavones; Lung metastasis

Indexed keywords

ANTINEOPLASTIC AGENT; DAIDZEIN; EQUOL; GENISTEIN; ISOFLAVONE DERIVATIVE; KI 67 ANTIGEN; MKI67 PROTEIN, MOUSE;

ANIMAL; BAGG ALBINO MOUSE; BLOOD; BONE NEOPLASMS; BREAST NEOPLASMS; CANCER TRANSPLANTATION; CELL PROLIFERATION; DIET; DIET SUPPLEMENTATION; DISEASE MODEL; DRUG EFFECTS; FEMALE; LUNG NEOPLASMS; METABOLISM; MORTALITY; MOUSE; PATHOLOGY; PROGNOSIS; RANDOMIZATION; SECONDARY; SOY FOOD; TUMOR INVASION;

ANIMALS; ANTICARCINOGENIC AGENTS; BONE NEOPLASMS; BREAST NEOPLASMS; CELL PROLIFERATION; DIET; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; EQUOL; FEMALE; GENISTEIN; ISOFLAVONES; KI-67 ANTIGEN; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROGNOSIS; RANDOM ALLOCATION; SOY FOODS;

EID: 84939967310     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-015-9709-2     Document Type: Article

References (42)

1. Pavese JM, Farmer RL, Bergan RC (2010) Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metastasis Rev 29(3):465–482
2. Rosen PR, Groshen S, Saigo PE, Kinne DW, Hellman S (1989) A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol 7(3):355–366
3. Lee YT (1985) Patterns of metastasis and natural courses of breast carcinoma. Cancer Metastasis Rev 4(2):153–172
4. Hagemeister FB Jr, Buzdar AU, Luna MA, Blumenschein GR (1980) Causes of death in breast cancer: a clinicopathologic study. Cancer 46(1):162–167
5. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ (2003) Cancer statistics. CA Cancer J Clin 53(1):5–26
6. Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12(20 Pt 2):6243s–6249s. doi:10.1158/1078-0432.CCR-06-0931
7. Braun S, Vogl FD, Naume B, Janni W, Osborne MP, Coombes RC, Schlimok G, Diel IJ, Gerber B, Gebauer G, Pierga JY, Marth C, Oruzio D, Wiedswang G, Solomayer EF, Kundt G, Strobl B, Fehm T, Wong GY, Bliss J, Vincent-Salomon A, Pantel K (2005) A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 353(8):793–802. doi:10.1056/NEJMoa050434
8. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE (1991) Dietary effects on breast-cancer risk in Singapore. Lancet 337(8751):1197–1200
9. Wu AH, Yu MC, Tseng CC, Pike MC (2008) Epidemiology of soy exposures and breast cancer risk. Br J Cancer 98(1):9–14
10. Messina M, Hilakivi-Clarke L (2009) Early intake appears to be the key to the proposed protective effects of soy intake against breast cancer. Nutr Cancer 61(6):792–798. doi:10.1080/01635580903285015
11. Allred CD, Allred KF, Ju YH, Virant SM, Helferich WG (2001) Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res 61(13):5045–5050
12. Lloyd KB, Hornsby LB (2009) Complementary and alternative medications for women’s health issues. Nutr Clin Pract 24(5):589–608
13. Tempfer CB, Froese G, Heinze G, Bentz EK, Hefler LA, Huber JC (2009) Side effects of phytoestrogens: a meta-analysis of randomized trials. Am J Med 122(10):939–946 e939
14. van Tonder E, Herselman MG, Visser J (2009) The prevalence of dietary-related complementary and alternative therapies and their perceived usefulness among cancer patients. J Hum Nutr Diet 22(6):528–535
15. Setchell KD (1998) Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68(6 Suppl):1333S–1346S
16. Yuan JP, Wang JH, Liu X (2007) Metabolism of dietary soy isoflavones to equol by human intestinal microflora–implications for health. Mol Nutr Food Res 51(7):765–781
17. Bowey E, Adlercreutz H, Rowland I (2003) Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem Toxicol 41(5):631–636
18. Magee PJ, McGlynn H, Rowland IR (2004) Differential effects of isoflavones and lignans on invasiveness of MDA-MB-231 breast cancer cells in vitro. Cancer Lett 208(1):35–41
19. Shao ZM, Wu J, Shen ZZ, Barsky SH (1998) Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res 58(21):4851–4857
20. Zhang Y, Zhu G, Gu S, Chen X, Hu H, Weng S (2010) Genistein inhibits osteolytic bone metastasis and enhances bone mineral in nude mice. Environ Toxicol Pharmacol 30(1):37–44. doi:10.1016/j.etap.2010.03.016
21. Martinez-Montemayor MM, Otero-Franqui E, Martinez J, De La Mota-Peynado A, Cubano LA, Dharmawardhane S (2010) Individual and combined soy isoflavones exert differential effects on metastatic cancer progression. Clin Exp Metastasis 27(7):465–480. doi:10.1007/s10585-010-9336-x
22. Zhang Y, Li Q, Chen H (2013) DNA methylation and histone modifications of Wnt genes by genistein during colon cancer development. Carcinogenesis 34(8):1756–1763. doi:10.1093/carcin/bgt129
23. Reeves PG, Nielsen FH, Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123(11):1939–1951
24. Twaddle NC, Churchwell MI, Doerge DR (2002) High-throughput quantification of soy isoflavones in human and rodent blood using liquid chromatography with electrospray mass spectrometry and tandem mass spectrometry detection. J Chromatogr B Analyt Technol Biomed Life Sci 777(1–2):139–145
25. Hong X, Liu Y, Hu G, Zhao D, Shen J, Shen F, Cao X, Wang Q (2009) EBAG9 inducing hyporesponsiveness of T cells promotes tumor growth and metastasis in 4T1 murine mammary carcinoma. Cancer Sci 100(5):961–969
26. Lewis JD, Shearer MH, Kennedy RC, Bright RK (2005) Surrogate tumor antigen vaccination induces tumor-specific immunity and the rejection of spontaneous metastases. Cancer Res 65(7):2938–2946
27. Hiraga T, Williams PJ, Ueda A, Tamura D, Yoneda T (2004) Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model. Clin Cancer Res 10(13):4559–4567
28. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410(6824):50–56
29. Ju YH, Fultz J, Allred KF, Doerge DR, Helferich WG (2006) Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice. Carcinogenesis 27(4):856–863
30. Jun JY, Griffith JW, Bruggeman R, Washington S, Demers LM, Verderame MF, Manni A (2008) Effects of polyamine depletion by alpha-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells. Breast Cancer Res Treat 107(1):33–40
31. Allred CD, Twaddle NC, Allred KF, Goeppinger TS, Churchwell MI, Ju YH, Helferich WG, Doerge DR (2005) Soy processing affects metabolism and disposition of dietary isoflavones in ovariectomized BALB/c mice. J Agric Food Chem 53(22):8542–8550
32. Weiss L (1992) Comments on hematogenous metastatic patterns in humans as revealed by autopsy. Clin Exp Metastasis 10(3):191–199
33. Wiedswang G, Borgen E, Karesen R, Kvalheim G, Nesland JM, Qvist H, Schlichting E, Sauer T, Janbu J, Harbitz T, Naume B (2003) Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J Clin Oncol 21(18):3469–3478. doi:10.1200/JCO.2003.02.009
34. Braun S, Pantel K, Muller P, Janni W, Hepp F, Kentenich CR, Gastroph S, Wischnik A, Dimpfl T, Kindermann G, Riethmuller G, Schlimok G (2000) Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 342(8):525–533. doi:10.1056/NEJM200002243420801
35. Vantyghem SA, Wilson SM, Postenka CO, Al-Katib W, Tuck AB, Chambers AF (2005) Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model. Cancer Res 65(8):3396–3403
36. Chen J, Thompson LU (2003) Lignans and tamoxifen, alone or in combination, reduce human breast cancer cell adhesion, invasion and migration in vitro. Breast Cancer Res Treat 80(2):163–170
37. Farina HG, Pomies M, Alonso DF, Gomez DE (2006) Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. Oncol Rep 16(4):885–891
38. Xu X, Wang HJ, Murphy PA, Cook L, Hendrich S (1994) Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 124(6):825–832
39. Mathey J, Lamothe V, Coxam V, Potier M, Sauvant P, Pelissero CB (2006) Concentrations of isoflavones in plasma and urine of post-menopausal women chronically ingesting high quantities of soy isoflavones. J Pharm Biomed Anal 41(3):957–965
40. Chang HC, Churchwell MI, Delclos KB, Newbold RR, Doerge DR (2000) Mass spectrometric determination of Genistein tissue distribution in diet-exposed Sprague-Dawley rats. J Nutr 130(8):1963–1970
41. Banka CL, Lund CV, Nguyen MT, Pakchoian AJ, Mueller BM, Eliceiri BP (2006) Estrogen induces lung metastasis through a host compartment-specific response. Cancer Res 66(7):3667–3672
42. Yang X, Belosay A, Du M, Fan TM, Turner RT, Iwaniec UT, Helferich WG (2013) Estradiol increases ER-negative breast cancer metastasis in an experimental model. Clin Exp Metastasis 30(6):711–721. doi:10.1007/s10585-012-9559-0